Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 10 | 2024 | 178 | 1.660 |
Why?
|
| Calcium | 5 | 2024 | 496 | 1.430 |
Why?
|
| Atrial Fibrillation | 2 | 2024 | 186 | 1.330 |
Why?
|
| Mitochondria, Heart | 6 | 2020 | 24 | 1.330 |
Why?
|
| Calcium Channels | 3 | 2020 | 125 | 1.330 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2024 | 2 | 0.930 |
Why?
|
| Spermine | 2 | 2020 | 5 | 0.760 |
Why?
|
| Heart Atria | 1 | 2020 | 74 | 0.700 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2020 | 110 | 0.690 |
Why?
|
| Calcium Signaling | 1 | 2020 | 171 | 0.630 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 65 | 0.570 |
Why?
|
| Animals | 15 | 2024 | 4634 | 0.530 |
Why?
|
| Mitochondria | 3 | 2024 | 84 | 0.520 |
Why?
|
| Nanoparticles | 4 | 2020 | 14 | 0.400 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 130 | 0.400 |
Why?
|
| Rabbits | 2 | 2024 | 283 | 0.390 |
Why?
|
| Action Potentials | 2 | 2024 | 139 | 0.380 |
Why?
|
| Silicon Dioxide | 3 | 2020 | 4 | 0.360 |
Why?
|
| Rats | 8 | 2020 | 873 | 0.350 |
Why?
|
| Myocardial Contraction | 2 | 2021 | 77 | 0.330 |
Why?
|
| Heart | 3 | 2020 | 96 | 0.320 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2019 | 13 | 0.320 |
Why?
|
| Cell Hypoxia | 2 | 2019 | 13 | 0.310 |
Why?
|
| Cardiotoxicity | 2 | 2018 | 10 | 0.300 |
Why?
|
| Oxidative Stress | 5 | 2020 | 131 | 0.280 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 252 | 0.240 |
Why?
|
| Membrane Potential, Mitochondrial | 3 | 2020 | 13 | 0.230 |
Why?
|
| Antioxidants | 1 | 2024 | 61 | 0.220 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 7 | 0.210 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2022 | 39 | 0.200 |
Why?
|
| Myocardium | 2 | 2020 | 145 | 0.200 |
Why?
|
| Cardiotonic Agents | 2 | 2019 | 14 | 0.200 |
Why?
|
| Rats, Wistar | 5 | 2020 | 45 | 0.190 |
Why?
|
| Atrial Function | 1 | 2021 | 14 | 0.190 |
Why?
|
| Hemagglutinins, Viral | 2 | 2010 | 2 | 0.190 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 23 | 0.180 |
Why?
|
| Cell Survival | 2 | 2020 | 165 | 0.180 |
Why?
|
| Kinetics | 1 | 2020 | 228 | 0.180 |
Why?
|
| Heart Rate | 1 | 2020 | 152 | 0.170 |
Why?
|
| Copper | 2 | 2018 | 12 | 0.170 |
Why?
|
| Quercetin | 1 | 2019 | 10 | 0.170 |
Why?
|
| Hypothyroidism | 1 | 2019 | 32 | 0.170 |
Why?
|
| Apoptosis | 2 | 2018 | 259 | 0.160 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 14 | 0.160 |
Why?
|
| RNA Interference | 1 | 2017 | 34 | 0.140 |
Why?
|
| Cyclosporine | 1 | 2017 | 16 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2017 | 68 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2017 | 53 | 0.140 |
Why?
|
| Cell Line | 1 | 2017 | 299 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 153 | 0.140 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 8 | 0.130 |
Why?
|
| Mitochondrial Membranes | 1 | 2016 | 4 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2017 | 323 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 350 | 0.130 |
Why?
|
| Male | 7 | 2020 | 15851 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2014 | 11 | 0.120 |
Why?
|
| Protein Folding | 2 | 2010 | 22 | 0.120 |
Why?
|
| Influenza Vaccines | 2 | 2010 | 13 | 0.110 |
Why?
|
| Escherichia coli | 2 | 2010 | 61 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2020 | 682 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 19 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 254 | 0.090 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 44 | 0.080 |
Why?
|
| Ventricular Fibrillation | 2 | 2019 | 32 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 456 | 0.070 |
Why?
|
| Isoproterenol | 2 | 2017 | 16 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2017 | 19 | 0.070 |
Why?
|
| Glutathione | 2 | 2017 | 32 | 0.070 |
Why?
|
| Mice | 2 | 2022 | 1629 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2022 | 52 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 89 | 0.050 |
Why?
|
| Ferrets | 2 | 2010 | 15 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2010 | 89 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 69 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 133 | 0.040 |
Why?
|
| Propylthiouracil | 1 | 2019 | 1 | 0.040 |
Why?
|
| Antithyroid Agents | 1 | 2019 | 1 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| Cytosol | 1 | 2019 | 63 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 355 | 0.040 |
Why?
|
| Humans | 5 | 2021 | 29814 | 0.040 |
Why?
|
| Coordination Complexes | 1 | 2018 | 3 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 4 | 0.040 |
Why?
|
| Serum | 1 | 2017 | 9 | 0.040 |
Why?
|
| Leptin | 1 | 2017 | 23 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 56 | 0.040 |
Why?
|
| Adsorption | 1 | 2017 | 5 | 0.040 |
Why?
|
| Nanostructures | 1 | 2017 | 13 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 25 | 0.040 |
Why?
|
| Echocardiography | 1 | 2017 | 173 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 223 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2017 | 106 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 138 | 0.030 |
Why?
|
| Ruthenium Compounds | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 30 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 24 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 51 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 744 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 778 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 8 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 14 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 16 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2010 | 12 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 63 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 75 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 82 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 132 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 156 | 0.020 |
Why?
|
Oropeza-Almazán's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(109)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_